Cabrera-Ramírez JF, Gallardo-Ollervides FJ, Flores-Miranda WA, Moreno-Reynoso AS, Aguirre-Alvardo A, Alfaro-Iraheta FA, López-Chavira A, Albino-Pacheco M, Serrano-Cuevas S, Tellez-Galicia DM, Alberto-Flores C, Albores-Méndez EM, Nava-Domínguez VH, Romo-Magdaleno JA

Language: Spanish
References: 13
Page: 53-58
PDF size: 219.59 Kb.

ABSTRACT

Background: Idiopathic sudden sensorineural hypoacusis is characterized by the sudden decrease of hearing in 30 decibels or more in at least three consecutive frequencies, an accurate cause that conditions this disease is unknown and therefore, the treatment must be instituted as early as possible.
Objective: To determine the effect of hyperbaric oxygen therapy as a complementary therapy to the steroid treatment of idiopathic sudden sensorineural hypoacusis.
Material and Method: A clinical, prospective, experimental, comparative controlled and randomized trial was done from January 2012 to November 2014, including patients diagnosed with idiopathic sudden sensorineural hypoacusis. Two study groups were formed: oral steroids and oral steroids plus hyperbaric oxygen therapy. We performed audiometries at the beginning, 10 and 20 days of treatment to determine the hearing gain with the average of pure tones (PTA) in decibels (dB).
Results: There were included 32 patients; treatment group with steroids plus hyperbaric oxygen therapy (n = 16) had a significantly higher hearing gain (mean = 44.7 dB) than patients in the oral steroid treatment group (n = 16; mean = 23 dB, t = -2.712, df = 30 , p = 0.011).
Conclusions: The addition of hyperbaric oxygen therapy to oral steroid therapy provides a significant additional improvement in hearing gain, the greatest hearing gain occurred in the first 10 days of treatment.

REFERENCES

1. Alimoglu Y, Inci E, Edizer DT, Ozdilek A, Aslan M. Efficacy comparison of oral steroid, intratympanic steroid, hyperbaric oxygen and oral steroid and hyperbaric oxygen treatments in idiopathic sudden sensorineural hearing loss cases. Eur Arch Otorhinolaryngol 2011 Dec;268(12):1735- 1741.

2. Bennett MH, Kertesz T, Perleth M, Yeung P, Lehm JP. Hyperbaric oxygen for idiopathic sudden sensorineural hearing loss and tinnitus. Cochrane Database Syst Rev 2012 Oct 17;10:CD004739. DOI: 10.1002/14651858.CD004739.pub4

3. National Institute of Deafness and Communication Disorders. Sudden deafness. 2000. http://www.nidcd.nih. gov/health/hearing/sudden.htm. Accessed May 18, 2011.

4. Thurmond M, Amedee RG. Sudden sensorineural hearing loss: etiologies and treatments. J Louisiana State Medical Society 1998 May 1;150(5):200-203.

5. Merchant NS, Durand LM, Adams CJ. Sudden deafness: Is it viral? ORL J Otorhinolaryngol Relat Spec 2008;70(1):52-62.

6. Jourdy DN, Donatelli LA, Victor JD, Selesnick SH. Assessment of variation throughout the year in the incidence of idiopathic sudden sensorineural hearing loss. Otol Neurotol 2010 Jan;31(1):53-7.

7. Yood HT, Paparella MM, Schacern AP, Alleva M. Histopathology of sudden hearing loss. Laryngoscope 1990 Jul;100(7):707-15.

8. Plaza G, Durio E, Herráiz C, Rivera T, García-Berrocal J. Consensus on diagnosis and treatment of sudden hearing loss. Acta Otorrinolaringol Esp 2011;62(2):144-157.

9. Stachler JR, Chandrasekhar SS, Archer MS et al. Clinical practice guideline: Sudden Hearing Loss. Otolaryngol Head Neck Surg 2012;146(1S):S1-S35. DOI: 10.1177/0194599812436449

10. Weaver KL. Hyperbaric oxygen therapy indications. Undersea and Hyperbaric Medical Society. 13a edition. April 2014. pp139-149.

11. Liu Y-C, Chi F-H, Yang T-H, Liu T-C. Assessment of complications due to intratympanic injections. World J Otorhinolaryngol Head Neck Surg 2016;2(1):13-16. doi:10.1016/j. wjorl.2015.11.001.

12. Topuz E, Yigit O, Cinar U, Seven H. Should hyperbaric oxygen be added to treatment in idiopathic sudden sensorineural hearing loss? Eur Arch Otorhinolaryngol 2004;261(7):393-396.

13. Cekin E, Cincik H, Ulubil SA, Gungor A. Effectiveness of hyperbaric oxygen therapy in management of sudden hearing loss. J Lar yngol Otol 2009 Jun;123(6):609-612.